Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.

Chest - 1 Nov 2000

Lieberman J

Abstract excerpt

STUDY OBJECTIVES: To propose an hypothesis that antiprotease augmentation therapy reduces the incidence of lung infections in alpha(1)-antitrypsin (AAT)-deficient patients, and to present supporting data. DESIGN: The proposed concept is based on a survey taken via the Internet of patients receiving augmentation therapy for 1 to 10 years compared to similar patients not receiving such therapy. SETTING: A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin
Share to alpha 1-Antitrypsin Deficiency
Share to Infections

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Internet

Share to Lung Diseases

Share to Pulmonary Emphysema

Share to Quality of Life

Share to Trypsin Inhibitors

Source

Identifiers

PMID: 11083705
DOI: 10.1378/chest.118.5.1480

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.PMID 11083705Read ↗

Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank.Semantic proximity Read ↗

Alpha-1 Antitrypsin Augmentation TherapySemantic proximity Read ↗

The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.Semantic proximity Read ↗

Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor.Semantic proximity Read ↗

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.Semantic proximity Read ↗

Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events.Semantic proximity Read ↗

Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.Semantic proximity Read ↗

[Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].Semantic proximity Read ↗

The direct medical costs of alpha(1)-antitrypsin deficiency.Semantic proximity Read ↗

Emerging drugs for alpha-1-antitrypsin deficiency.Semantic proximity Read ↗

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.Semantic proximity Read ↗

alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.